October 22, 2020
Health News

First U.K. patient receives COVID-19 trial drug – MarketWatch

The first U.K. patient has been treated with an experimental drug for severe lung disease related to Covid-19, the Manchester University NHS Foundation Trust said Monday.
The patient is part of the Oscar study conducted by U.K. pharmaceutical giant GlaxoSmithKline PLC, set up to investigate whether one of its pipeline drugs, Otilimab, can help reduce the effects of the so-called cytokine storm–a severe immune reaction where the body starts to attack its own cells–which was found to occur in s…

Click here to view the original article.

Related Posts

You might also like ...

post featured image
Rheumatoid arthritis drug falls short as treatment for hospitalized Covid-19 patients in three studies – CNN
post featured image
Covid-19 vaccine trials won’t tell us if the shots save lives, expert notes – CNN
post featured image
Cost of another Utah Olympics rising as coronavirus adds to risks – Deseret News